710278000: Idelalisib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Phosphoinositide 3 kinase inhibitor\Idelalisib (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Idelalisib (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Purine and/or purine derivative\Idelalisib (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Purine and/or purine derivative\Idelalisib (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Idelalisib (substance)
\Organic compound\Organic nitrogen compound\Purine and/or purine derivative\Idelalisib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3044258013 Idelalisib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3044278017 Idelalisib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Idelalisib (substance)	Is a	Phosphoinositide 3 kinase inhibitor	true	Inferred relationship	Some
Idelalisib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Phosphoinositide 3 kinase inhibitor (disposition)	true	Inferred relationship	Some
Idelalisib (substance)	Is a	kemisk stof specificeret iht. funktion	false	Inferred relationship	Some
Idelalisib (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Idelalisib (substance)	Is a	Amine (substance)	false	Inferred relationship	Some
Idelalisib (substance)	Is a	Purine	false	Inferred relationship	Some
Idelalisib (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Idelalisib (substance)	Is a	Fluorine compound	false	Inferred relationship	Some
Idelalisib (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Idelalisib (substance)	Is a	Purine and/or purine derivative	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing idelalisib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Idelalisib (substance)	Inferred relationship	Some	1
Idelalisib only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Idelalisib (substance)	Inferred relationship	Some	1
Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Idelalisib (substance)	Inferred relationship	Some	1
Product containing precisely idelalisib 150 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Idelalisib (substance)	Inferred relationship	Some	1
Idelalisib-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Idelalisib (substance)	Inferred relationship	Some	1
Idelalisib only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Idelalisib (substance)	Inferred relationship	Some	1
Product containing precisely idelalisib 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Idelalisib (substance)	Inferred relationship	Some	1
Product containing precisely idelalisib 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Idelalisib (substance)	Inferred relationship	Some	1

This concept is not in any reference sets